A spectrum of mutations in SH2D1A that causes x-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses

Leukemia and Lymphoma

Volumn 43, Issue 6, 2002, Pages 1189-1201

  Sumegi, Janos ^a   Seemayer, Thomas A ^b   Huang, Dali ^a   Davis, Jack R ^b   Morra, Massimo ^c   Gross, Thomas G ^d   Yin, Luo ^e   Romco, Giovanni ^e   Klein, Eva ^f   Terhorst, Cox ^c   Lanyi, Arpad ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^f KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Mutations; SH2D1A; T and B cells; X linked lymphoproliferative disease

Indexed keywords

ADAPTOR PROTEIN; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; CD150 ANTIGEN; CELL SURFACE RECEPTOR; DNA BINDING PROTEIN; DOK1 PROTEIN, HUMAN; DOK1 PROTEIN, MOUSE; GAP ASSOCIATED PROTEIN P62; GAP-ASSOCIATED PROTEIN P62; GLYCOPROTEIN; IMMUNOGLOBULIN; LEUKOCYTE ANTIGEN; PHOSPHOPROTEIN; RNA BINDING PROTEIN; SH2D1A PROTEIN, HUMAN; SH2D1A PROTEIN, MOUSE; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CHROMOSOME XQ; CONTROLLED STUDY; CRYSTAL STRUCTURE; EPSTEIN BARR VIRUS; GENE LOCUS; GENE MAPPING; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREGULATION; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; VIRUS INFECTION; X CHROMOSOME LINKAGE; ANIMAL; B LYMPHOCYTE; CHEMISTRY; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; MULTIGENE FAMILY; MUTATION; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE; VIROLOGY; X CHROMOSOME;

ANIMAL; B-LYMPHOCYTES; CARRIER PROTEINS; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS INFECTIONS; GLYCOPROTEINS; HUMAN; IMMUNOGLOBULINS; KILLER CELLS, NATURAL; LYMPHOPROLIFERATIVE DISORDERS; MICE; MICE, KNOCKOUT; MULTIGENE FAMILY; MUTATION; PHOSPHOPROTEINS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; X CHROMOSOME; ANIMALS; ANTIGENS, CD; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; RECEPTORS, CELL SURFACE;

EID: 0035992264     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190290026240     Document Type: Review

References (79)

1. "X-linked recessive progressive combined variable immunodeficiency (Duncan's disease)"
2. "Sap controls T cell responses to virus and terminal differentiation of TH2 cells"
3. "X-linked lymphoproliferative disease: Twenty-five years after the discovery"
4. "Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP)"
5. "Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked proliferative disease"
6. "The aberrant host response to EBV infection in X-linked Lymphoproliferative disease results from mutations in a novel SH2-domain encoding gene, SH2D1A"
7. "Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome"
8. "The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM"
9. "Genomic organization and characterization of mouse SH2D1A, the gene that is altered in X-linked lymphoproliferative disease"
10. "Missense mutations that affect non-phospho-tyrosine interactions and stability of the SAP/SH2D1A SH2-domain in X-linked lymphoproliferative disease patients"
11. "SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines"
12. "Eat-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene"
13. "Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in immunocytes"
14. "Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition"
15. "Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A"
16. "Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure"
17. "Molecular cloning of the lymphocyte activation marker Blast-1"
18. "An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2"
19. "A novel receptor involved in T-cell activation"
20. "CD84 leukocyte antigen is a new member of the Ig superfamily"
21. "Isolation and characterization of cDNA clones for mouse Ly-9"
22. "Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes"
23. "A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells"
24. "Cloning, expression, and function of blame, a novel member of the cd2 family"
25. "Molecular cloning of CS1, a novel human natural killer cell receptor belonging to the CD2 subset of the immunoglobulin superfamily"
26. "The immunoglobulin superfamily-domains for cell surface recognition"
27. "Structure, expression, and genetic linkage of the mouse BCM1 (OX45 or Blast-1) antigen. Evidence for genetic duplication giving rise to the BCM1 region on mouse chromosome 1 and the CD2/LFA3 region on mouse chromosome 3"
28. "CD2 and the nature of protein interactions mediating cell-cell recognition"
29. "2B4, the natural killer and T cell immunogolobulin superfamily surface protein, is a ligand for CD48"
30. "The CD2-subset of the Ig superfamily of cell surface molecules: Receptor-ligand pairs expressed by NK cells and other immune cells"
31. "Human 2B4, an activating natural killer cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP"
32. "Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative gene product SAP"
33. "CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A"
34. "Engagement of the signalling activation molecule (SLAM) on activated T cells result in IL-2 independent, cyclosporin A sensitive T cell proliferation and IFN-γ production"
35. "CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis"
36. "Identification of human src homology 2-containing protein-tyrosine-phosphatase: A putative homolog of Drosophila corkscrew"
37. "Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human PDGF-R"
38. "Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains"
39. "Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2"
40. "Genomic organization and characterization of mouse SAP, the gene that is altered in X-linked lymphoproliferative disease"
41. "Shc interaction with Src homology 2 domain containing inositol phosphatase (SHIP) in vivo requires the Shc-phosphotyrosine binding domain and two specific phosphotyrosines on SHIP"
42. "A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells"
43. "2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48"
44. "Identification of the 2B4 molecule as a counter-receptor for CD48"
45. "Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes"
46. "Activating interactions in human NK cell recognition: The role of 2B4-CD48"
47. "Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48"
48. "Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome"
49. "Defective NK cell activation in X-linked lymphoproliferative disease"
50. "X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells"
51. "Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4"
52. "A 62 kilodalton tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogenous leukemia enriched lineage negative blast populations"
53. "p62(dok): A constitutively tyrosine-phosphorylated GAP-associated protein in chronic myelogenous leukemia progenitor cells"
54. "Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins"
55. "Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling"
56. "Role of the rasGAP-associated docking protein p62(dok) in negative regulation of B cell receptor-mediated signaling"
57. "The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B"
58. "Domain-dependent function of the rasGAP-binding protein p62Dok in cell signaling"
59. "Multipoint linkage mapping of the Xq25-q26 region in a family affected by the X-linked lymphoproliferative syndrome"
60. "A new candidate region for the positional cloning of the XLP gene"
61. "SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients"
62. "Recurrent B-cell non-Hodgkin's lymphoma in two brothers with X-linked lymphoproliferative disease without evidence for Epstein-Barr virus infection"
63. "Structural basis for SH2D1A mutations in X-linked lymphoproliferative disease"
64. "X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein"
65. "Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene"
66. "Lymphocytic vasculities in X-linked lymphoproliferative disease"
67. "Large deletion of the X-linked lymphoproliferative disease gene detected by fluorescence in situ hybridization"
68. "Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression"
69. "Identification of residues in GTPase activating protein Src homology 2 domains that control binding to tyrosine phosphorylated growth factor receptors and p62"
70. "Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo"
71. "Mutations in btk in patients with presumed X-linked agammaglobulinenia"
72. "Alterations of the X-linked lymphoproliferative disease gene SAP/SH2D1A in the Common Variable Immunodeficiency syndrome"
73. "SH2D1A mutations in Japanese males with severe Epstein-Barr virus-associated illnesses"
74. "Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP"
75. "DSHP: A "power bar" for sustained immune responses"
76. "The gene defective in X-linked lymphoproliferative disease controls T cells dependent immune surveillance against Epstein-Barr virus"
77. "The abnormal gene in X-linked lymphoproliferative syndrome"
78. "Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product"